Jan. 6 at 12:33 PM
Biotechs that hit 52-week highs yesterday:
$CDTX: Shares hit
$221.24 following a
$9.2B acquisition deal by Merck.
$DRTS hit a 2-year high yesterday after submitting its first FDA PMA module for Alpha DaRT. With ASCO GI (Jan 8-10) and the JPM Healthcare Conference (Jan 15) ahead, the stock is primed for a breakout toward the
$8.00 analyst target.
$CRNX: Reached
$55.23 on strong launch revenue and positive Phase 2 clinical data.
$CRL: Hit
$207.14 after a BofA upgrade to Buy with a
$225 price target
TASH: Touched a 1-year peak following a Goldman Sachs upgrade to an
$11 target
